药明生物入选标普全球《可持续发展年鉴2026》

医药健闻
Mar 02

(医药健闻2026年3月02日讯)全球领先的合同研究、开发和生产(CRDMO)服务公司药明生物宣布,凭借2025年在可持续发展领域的卓越表现,公司入选标普全球(S&P Global)《可持续发展年鉴2026》,并在标普全球企业可持续发展评估(CSA)中位列行业前茅,跻身全球前1%。这是药明生物连续四年获此殊荣。该《年鉴》基于标普全球CSA,评选出各行业在可持续发展方面表现优异的企业。在2025年...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10